Diabetic Nephropathy Type 2: Clinical Trials

4 trials for Diabetic Nephropathy Type 2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 completed, 1 unknown. 4 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Not yet recruiting 2, Completed 1, Unknown 1
Phase 23Not yet recruiting 2, Unknown 1

Follow Diabetic Nephropathy Type 2: new trials by email Literature Review of Diabetic Nephropathy Type 2 trials Research Report on Diabetic Nephropathy Type 2

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vitamin D in Diabetic Neuropathy
Vitamin D - Diabetic Nephropathy Type 2
Phase 2 / Phase 3Not yet recruitingTanta University1502026-10-012026-09-08
Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy
Acetylsalicylic Acid, Placebo - Diabetic Nephropathy Type 2
Phase 2 / Phase 3Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine3552024-01-012023-10-05
Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease
Empagliflozin 25 MG, Enalapril Maleate 20 mg - Diabetic Nephropathy Type 2
Phase 2 / Phase 3UnknownOmar Tarek Elfarargi2122023-03-012022-05-13
Investigational and Comparative Study in the Management of Diabetic Nephropathy
Tadalafil 20Mg Oral Tablet, Pentoxifylline 400 MG Oral Tablet - Diabetic Nephropathy Type 2
Phase 3CompletedTanta University902022-02-012024-05-14

Narrower conditions

Diabetic Nephropathies (1)

Broader conditions

Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Aspirin (1)  ·  Enalapril (1)  ·  Pentoxifylline (1)  ·  Tablets (1)  ·  Tadalafil (1)  ·  Vitamin D (1)  ·  empagliflozin (1)

Sponsors

Tanta University (2)  ·  Omar Tarek Elfarargi (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)

Countries

Egypt (1)

Top investigators

Omar T Elfarargi (1)  ·  Wafaa S Hegab, Lecturer (1)

Results publications

PMID 38915115